EPHA2 and breast carcinoma: Although we found that EPHB2 was the most promising candidate in our breast cancer cohorts, EPHB2 together with EPHB6, EPHA2, EPHA4 and the ligands EFNB1 and EFNB2 were important to define prognostic relevant clusters.